Showing 5,901 - 5,920 results of 18,609 for search 'significantly ((((((lower decrease) OR (linear decrease))) OR (a decrease))) OR (greater decrease))', query time: 0.52s Refine Results
  1. 5901

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    “…After coincubation with edited CMCs, the proportions of CD8+CD69+ and CD8+CD44+ T cells significantly increase, while the proportion of CD4+Foxp3+ T<sub>regs</sub> notably decreases, indicating the restoration of immune responses. …”
  2. 5902

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    “…After coincubation with edited CMCs, the proportions of CD8+CD69+ and CD8+CD44+ T cells significantly increase, while the proportion of CD4+Foxp3+ T<sub>regs</sub> notably decreases, indicating the restoration of immune responses. …”
  3. 5903

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    “…After coincubation with edited CMCs, the proportions of CD8+CD69+ and CD8+CD44+ T cells significantly increase, while the proportion of CD4+Foxp3+ T<sub>regs</sub> notably decreases, indicating the restoration of immune responses. …”
  4. 5904

    Demographic and clinical data at baseline. by Karel Joineau (21799908)

    Published 2025
    “…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”
  5. 5905

    Changes in clinical variables. by Karel Joineau (21799908)

    Published 2025
    “…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”
  6. 5906
  7. 5907
  8. 5908
  9. 5909
  10. 5910
  11. 5911
  12. 5912

    Unraveling the Anticancer Potential of SSRIs in Prostate Cancer by Combining Computational Systems Biology and <i>In Vitro</i> Analyses by Sanaa K. Bardaweel (9636542)

    Published 2025
    “…The combination of SSRIs with cisplatin, 5-fluorouracil, and raloxifene resulted in either synergistic or additive effects. SSRIs resulted in a significant increase in the early and late apoptotic activity in PC3 cells. …”
  13. 5913
  14. 5914
  15. 5915
  16. 5916
  17. 5917
  18. 5918
  19. 5919
  20. 5920